Harvard Apparatus Regenerative Technology
About:
Harvard Apparatus Regenerative Technology is a biotechnology firm developing esophageal implants for patients battling threatening condition
Website: https://hregen.com/
Twitter/X: BiostageInc
Top Investors: Connecticut Children’s Medical Center, Bin Zhao
Description:
Biostage is a biotechnology company developing esophageal implants for patients battling life-threatening conditions. It uses the patient’s stem cells grown on a porous plastic tubular scaffold to regenerate the esophagus after it has been removed by a surgeon due to cancer, trauma, or birth defects. Once the regeneration is complete, typically after about 3 months, the scaffold is removed via the mouth. It requires no surgical incision to remove the scaffold.
$37.1M
Less than $1M
Holliston, Massachusetts, United States
2012-05-03
bioscience(AT)harvardapparatus.com
David Green
11-50
2024-08-19
Public
© 2025 bioDAO.ai